Lumexa Imaging (NASDAQ:LMRI) Stock Rating Upgraded by Wall Street Zen

Lumexa Imaging (NASDAQ:LMRI) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Sunday.

A number of other equities analysts have also issued reports on the company. Weiss Ratings raised Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. Deutsche Bank Aktiengesellschaft set a $16.00 price objective on Lumexa Imaging in a report on Thursday. Finally, Barclays decreased their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Lumexa Imaging currently has an average rating of “Moderate Buy” and an average price target of $16.00.

Lumexa Imaging Stock Down 1.7%

LMRI stock opened at $11.81 on Friday. The firm’s 50-day moving average is $10.92 and its two-hundred day moving average is $10.88. The company has a market capitalization of $1.13 billion and a price-to-earnings ratio of -20.02. Lumexa Imaging has a 52 week low of $6.45 and a 52 week high of $19.45. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 1.40.

Lumexa Imaging (NASDAQ:LMRI) last posted its quarterly earnings data on Wednesday, August 12th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.17. The company had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. On average, analysts forecast that Lumexa Imaging will post 0.27 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Lumexa Imaging

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jupiter Topco LLC acquired a new stake in Lumexa Imaging during the 2nd quarter worth about $24,269,000. Janus Henderson Group PLC boosted its holdings in shares of Lumexa Imaging by 5.4% in the first quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after buying an additional 107,903 shares during the period. T. Rowe Price Investment Management Inc. acquired a new position in shares of Lumexa Imaging in the fourth quarter worth about $37,139,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Lumexa Imaging in the fourth quarter worth approximately $27,750,000. Finally, ArrowMark Colorado Holdings LLC acquired a new stake in shares of Lumexa Imaging during the fourth quarter valued at approximately $27,750,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).